The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of mFOLFIRINOX in patients with borderline resectable and locally advanced unresectable pancreatic cancer: Intention-to-treat population analysis.
 
Inhwan Hwang
No Relationships to Disclose
 
Changhoon Yoo
Honoraria - Bayer; Bayer; Bayer; Bayer; Ipsen; Ipsen; Ipsen; Ipsen; SERVIER; SERVIER; SERVIER; SERVIER
Consulting or Advisory Role - LSK BioPharma; LSK BioPharma; LSK BioPharma; LSK BioPharma
Speakers' Bureau - Bayer; Bayer; Bayer; Bayer; Celgene; Celgene; Celgene; Celgene; Eisai; Eisai; Eisai; Eisai; Ipsen; Ipsen; Ipsen; Ipsen; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme
Research Funding - CKD pharm; CKD pharm; CKD pharm; CKD pharm; SERVIER; SERVIER; SERVIER; SERVIER
 
Kyu-Pyo Kim
No Relationships to Disclose
 
Jae Ho Byun
No Relationships to Disclose
 
Jae Ho Jeong
No Relationships to Disclose
 
Heung-Moon Chang
No Relationships to Disclose
 
Baek-Yeol Ryoo
No Relationships to Disclose